In last trading session, Milestone Pharmaceuticals Inc (NASDAQ:MIST) saw 1.13 million shares changing hands with its beta currently measuring 1.82. Company’s recent per share price level of $2.13 trading at -$0.08 or -3.62% at ring of the bell on the day assigns it a market valuation of $113.58M. That closing price of MIST’s stock is at a discount of -29.11% from its 52-week high price of $2.75 and is indicating a premium of 47.42% from its 52-week low price of $1.12.
For Milestone Pharmaceuticals Inc (MIST), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.40. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.15 in the current quarter.
Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information
Upright in the red during last session for losing -3.62%, in the last five days MIST remained trading in the red while hitting it’s week-highest on Wednesday, 02/12/25 when the stock touched $2.13 price level, adding 10.5% to its value on the day. Milestone Pharmaceuticals Inc’s shares saw a change of -9.75% in year-to-date performance and have moved -2.74% in past 5-day. Milestone Pharmaceuticals Inc (NASDAQ:MIST) showed a performance of 7.58% in past 30-days.
Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 78.7% to its current value. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 10. It follows that stock’s current price would drop -369.48% in reaching the projected high whereas dropping to the targeted low would mean a loss of -369.48% for stock’s current value.
Milestone Pharmaceuticals Inc (MIST) estimates and forecasts
This year revenue growth is estimated to fall -100.00% from the last financial year’s standing.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -7.22% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 54.82% while estimates for its earnings growth in next 5 years are of 26.29%.
Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s Major holders
BLACKROCK INC. is the top institutional holder at MIST for having 4.97 million shares of worth $6.56 million. And as of 2024-06-30, it was holding 9.9119 of the company’s outstanding shares.
The second largest institutional holder is RTW INVESTMENTS, LP, which was holding about 3.26 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.9211 of outstanding shares, having a total worth of $4.3 million.
On the other hand, SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF and Fidelity NASDAQ Composite Index Fund are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024 , the former fund manager was holding 19.12 shares of worth $40719.0 or 0.04% of the total outstanding shares. The later fund manager was in possession of 17.58 shares on Nov 30, 2024 , making its stake of worth around $37436.0 in the company or a holder of 0.03% of company’s stock.
